Search Results - "Gopalkrishnashetty Sreenivasmurthy, Sravan"
-
1
A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity in Vitro
Published in International journal of molecular sciences (22-02-2020)“…bstract TFEB (transcription factor EB), which is a master regulator of autophagy and lysosome biogenesis, is considered to be a new therapeutic target for…”
Get full text
Journal Article -
2
Targeting Aggrephagy for the Treatment of Alzheimer's Disease
Published in Cells (Basel, Switzerland) (28-01-2020)“…Alzheimer's disease (AD) is one of the most common neurodegenerative diseases in older individuals with specific neuropsychiatric symptoms. It is a…”
Get full text
Journal Article -
3
Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson's Disease
Published in International journal of molecular sciences (08-02-2019)“…The mammalian target of rapamycin (mTOR) signaling pathway plays a critical role in regulating cell growth, proliferation, and life span. mTOR signaling is a…”
Get full text
Journal Article -
4
A small molecule transcription factor EB activator ameliorates beta‐amyloid precursor protein and Tau pathology in Alzheimer's disease models
Published in Aging cell (01-02-2020)“…Accumulating studies have suggested that targeting transcription factor EB (TFEB), an essential regulator of autophagy‐lysosomal pathway (ALP), is promising…”
Get full text
Journal Article -
5
Traditional Chinese medicine compounds regulate autophagy for treating neurodegenerative disease: A mechanism review
Published in Biomedicine & pharmacotherapy (01-01-2021)“…[Display omitted] •Traditional Chinese Medicine (TCM) is important source for modern drug development.•The important role of autophagy in neurodegenerative…”
Get full text
Journal Article -
6
Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer's Disease
Published in International journal of molecular sciences (25-03-2022)“…Eukaryotic cells possess a plethora of regulatory mechanisms to maintain homeostasis and ensure proper biochemical functionality. Autophagy, a central,…”
Get full text
Journal Article -
7
Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies
Published in Journal of biomedical science (22-10-2022)“…Abstract Background Tauopathies are neurodegenerative diseases that are associated with the pathological accumulation of tau-containing tangles in the brain…”
Get full text
Journal Article -
8
TFEB, a master regulator of autophagy and biogenesis, unexpectedly promotes apoptosis in response to the cyclopentenone prostaglandin 15d-PGJ2
Published in Acta pharmacologica Sinica (01-05-2022)“…Transcriptional factor EB (TFEB), a master regulator of autophagy and lysosomal biogenesis, is generally regarded as a pro-survival factor. Here, we identify…”
Get full text
Journal Article -
9
-
10
A stress response p38 MAP kinase inhibitor SB202190 promoted TFEB/TFE3-dependent autophagy and lysosomal biogenesis independent of p38
Published in Redox biology (01-05-2020)“…TFEB (transcription factor EB) and TFE3 (transcription factor E3) are “master regulators” of autophagy and lysosomal biogenesis. The stress response p38…”
Get full text
Journal Article -
11
Identification of a novel AMPK-PEA15 axis in the anoikis-resistant growth of mammary cells
Published in Breast cancer research : BCR (06-08-2014)“…Matrix detachment triggers anoikis, a form of apoptosis, in most normal epithelial cells, while acquisition of anoikis resistance is a prime requisite for…”
Get full text
Journal Article -
12
Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models
Published in Frontiers in molecular biosciences (25-10-2022)“…Many neurodegenerative diseases, such as Alzheimer’s disease (AD) and frontotemporal dementia with Parkinsonism linked to chromosome 17, are characterized by…”
Get full text
Journal Article -
13
Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy
Published in Frontiers in molecular biosciences (26-10-2022)“…Emerging evidence from Alzheimer’s disease (AD) patients suggests that reducing tau pathology can restore cognitive and memory loss. To reduce tau pathology,…”
Get full text
Journal Article -
14
Interaction of Tau with Kinesin-1: Effect of Kinesin-1 Heavy Chain Elimination on Autophagy-Mediated Mutant Tau Degradation
Published in Biomedicines (01-01-2024)“…Natively unfolded tau has a low propensity to form aggregates, but in tauopathies, such as Alzheimer's disease (AD), tau aggregates into paired helical…”
Get full text
Journal Article -
15
Real-Time Detection and Visualization of Amyloid‑β Aggregates Induced by Hydrogen Peroxide in Cell and Mouse Models of Alzheimer’s Disease
Published in ACS applied materials & interfaces (11-01-2023)“…Oxidative stress, caused by an imbalance between the production and the accumulation of reactive oxygen species (ROS), is a prominent cause of the…”
Get full text
Journal Article -
16
Study of BDE-47 induced Parkinson’s disease-like metabolic changes in C57BL/6 mice by integrated metabolomic, lipidomic and proteomic analysis
Published in Journal of hazardous materials (15-10-2019)“…[Display omitted] •Omics study of BDE-47 induced metabolic changes in mice brain.•BDE-47 can disturb neurotransmitter production, endocytosis and…”
Get full text
Journal Article -
17
A Self-Assembled α‑Synuclein Nanoscavenger for Parkinson’s Disease
Published in ACS nano (25-02-2020)“…Although emerging evidence suggests that the pathogenesis of Parkinson’s disease (PD) is closely related to the aggregation of alpha-synuclein (α-syn) in the…”
Get full text
Journal Article -
18
Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington's disease
Published in Proceedings of the National Academy of Sciences - PNAS (24-09-2024)“…Huntington's disease (HD) and spinocerebellar ataxia type 3 (SCA3) are the two most prevalent polyglutamine (polyQ) neurodegenerative diseases, caused by CAG…”
Get full text
Journal Article -
19
Lysosomal TPCN (two pore segment channel) inhibition ameliorates beta-amyloid pathology and mitigates memory impairment in Alzheimer disease
Published in Autophagy (04-03-2022)“…Impairment of the macroautophagy/autophagy-lysosomal pathway (ALP) can lead to amyloid plaque accumulation in Alzheimer disease (AD); however, the underlying…”
Get full text
Journal Article -
20
Protopine promotes the proteasomal degradation of pathological tau in Alzheimer's disease models via HDAC6 inhibition
Published in Phytomedicine (Stuttgart) (01-02-2022)“…•The natural alkaloid protopine is brain-permeable, which improves memory functions in 3xTg-AD and P301S tau transgenic models of AD.•Protopine specifically…”
Get full text
Journal Article